Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued on Thursday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

NASDAQ CALA opened at $0.01 on Thursday. The stock’s 50 day moving average is $0.01 and its 200 day moving average is $0.02. Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.